ATC Group: L01DC01 Bleomycin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01DC01 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01D Cytotoxic antibiotics and related substances
4 L01DC Other cytotoxic antibiotics
5 L01DC01 Bleomycin

Active ingredients in L01DC01

Active Ingredient Description
Bleomycin

Bleomycin is a mixture of basic, water-soluble glycopeptide-antibiotics with cytotoxic activity. Bleomycin acts by interacting with both single and double-stranded DNA (deoxyribonucleic acid) leading to both single and double-strand scission, which leads in turn to inhibition of cell division, inhibition of growth and inhibition of DNA synthesis. Bleomycin can also influence RNA (ribonucleic acid) and protein biosynthesis to a lesser extent.

Medicines in this ATC group

Brazil (BR)

Ecuador (EC)

Estonia (EE)

Hong Kong (HK)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

Poland (PL)

South Africa (ZA)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.